Vinva Investment Management Ltd Grows Stock Holdings in Docusign Inc. $DOCU

Vinva Investment Management Ltd grew its position in shares of Docusign Inc. (NASDAQ:DOCU) by 1,017.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 146,770 shares of the company’s stock after acquiring an additional 133,630 shares during the quarter. Vinva Investment Management Ltd’s holdings in Docusign were worth $10,581,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewEdge Advisors LLC lifted its position in Docusign by 36.4% in the 1st quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock worth $749,000 after buying an additional 2,457 shares during the last quarter. Atria Investments Inc grew its position in Docusign by 5.6% during the second quarter. Atria Investments Inc now owns 8,455 shares of the company’s stock valued at $659,000 after acquiring an additional 449 shares during the last quarter. Moors & Cabot Inc. raised its stake in shares of Docusign by 5.7% during the second quarter. Moors & Cabot Inc. now owns 2,780 shares of the company’s stock worth $217,000 after acquiring an additional 150 shares in the last quarter. First Horizon Advisors Inc. raised its stake in shares of Docusign by 48.6% during the second quarter. First Horizon Advisors Inc. now owns 590 shares of the company’s stock worth $46,000 after acquiring an additional 193 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. lifted its holdings in shares of Docusign by 3.4% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 66,958 shares of the company’s stock worth $5,203,000 after acquiring an additional 2,232 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Docusign

In other news, insider James P. Shaughnessy sold 12,000 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the transaction, the insider directly owned 54,550 shares of the company’s stock, valued at approximately $3,656,486.50. This represents a 18.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the sale, the executive owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This represents a 8.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 77,476 shares of company stock valued at $5,302,678. Company insiders own 1.01% of the company’s stock.

Docusign Stock Up 1.0%

NASDAQ:DOCU opened at $48.69 on Monday. The firm has a market capitalization of $9.75 billion, a P/E ratio of 34.05, a P/E/G ratio of 2.12 and a beta of 1.03. The company has a fifty day moving average of $53.84 and a 200 day moving average of $65.77. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $94.67.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on DOCU. Royal Bank Of Canada cut their price objective on shares of Docusign from $95.00 to $70.00 and set a “sector perform” rating for the company in a research note on Monday, January 5th. HSBC set a $53.00 price target on shares of Docusign in a research note on Friday, February 13th. Jefferies Financial Group cut Docusign from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $45.00 in a research note on Monday, February 23rd. Zacks Research downgraded Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. Finally, Wedbush lowered their target price on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat, Docusign presently has an average rating of “Hold” and an average price target of $78.80.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.